Preventive drugs' value for money disputed

Many widely prescribed drugs for disease prevention lack valid evidence that they are cost effective and more should be done to assess real-world effectiveness, researchers have argued.

Writing in a BMJ editorial, Finnish researchers argued that efficacy data derived from clinical trials of preventive drugs such as statins and bisphosphonates are not valid evidence of good value for money in reality.

They claimed that benefits seen in carefully controlled trials may not apply in practice. Factors such as age, sex, provider compliance, patient adherence and diagnosis accuracy can all vary in reality.

‘This gap between the ideal and clinical circumstances raises the question of how well our most widely used preventive drugs work in real life,’ they said.

To illustrate the point, authors examined the effectiveness of bisphosphonates in Finland, basing outcomes on entry criteria relevant to clinical trials of the drug.

They estimated that treating all 1.86m citizens aged 50 years and over would prevent only 343 fractures.

‘Thus, although there are claims that important preventive drugs such as statins, antihypertensives, and bisphosphonates are cost effective, there are no valid data on the effectiveness, and particularly the cost effectiveness, in usual clinical care.’

The Finnish researchers said governments and drug approval bodies should promote and fund cost effectiveness trials, and they called for true comparative effectiveness research to become routine.

‘Unless this is done, the important question whether preventive pharmacotherapy is cost effective will remain unanswered.’

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Submit your session ideas for the RCGP Annual Conference 2019

Submit your session ideas for the RCGP Annual Conference 2019

GPs can now submit ideas for sessions at the RCGP Annual Conference in Liverpool,...

Scottish GP workforce increases for first time in 10 years, figures show

Scottish GP workforce increases for first time in 10 years, figures show

GP numbers in Scotland have risen slightly for the first time in 10 years despite...

More than 16m GP practice appointments a year lost to DNAs

More than 16m GP practice appointments a year lost to DNAs

More than 16m appointments at GP practices are lost every year because patients fail...

Six ways GPs can help patients with asthma to stay well this winter

Six ways GPs can help patients with asthma to stay well this winter

Up to 26,000 people could be hospitalised with asthma this winter. GP and Asthma...

Red flag symptoms: Hirsutism

Red flag symptoms: Hirsutism

There are a number of possible causes for this symptom, explains Dr Pipin Singh

A day in the life of a prison GP

A day in the life of a prison GP

Dr Patrick Staite tells GP Jobs what it is like to work as a prison GP.